United States Patent and Trademark Office Issues Composition of Matter Patent with BeyondSpring’s Lead Asset Plinabulin with Protection to 2036 – Nasdaq

United States Patent and Trademark Office Issues Composition of Matter Patent with BeyondSpring’s Lead Asset Plinabulin with Protection to 2036  Nasdaq

NEW YORK, Dec. 21, 2018– BeyondSpring Inc., a global biopharmaceutical company focused on the development of innovative cancer therapies, today.